Location of several putative genes possibly involved in human breast cancer progression

Cancer Research

Volumn 58, Issue 10, 1998, Pages 2081-2086

  Driouch, Keltouma ^a   Briffod, Marianne ^a   Bièche, Ivan ^a   Champème, Marie Hélène ^a   Lidereau, Rosette ^a  

^a CENTRE RENÉ HUGUENIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RECURRENCE; CHROMOSOME 3P; CHROMOSOME 7Q; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR GROWTH;

BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL;

EID: 0032523790     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bièche, I., and Lidereau, R. Genetic alterations in breast cancer. Genes Chromosomes Cancer, 14: 227-251, 1995.
2. Steeg, P. S., Bevilacqua, G., Kopper, L., Thorgeirsson, U. P., Talmadge, J. E., Liotta, L. A., and Sobel, M. E. Evidence for a novel gene associated with low tumor metastasic potential. J. Natl. Cancer Inst. (Bethesda), 80: 200-204, 1988.
3. Siitonen, S. M., Kononen, J. T., Helin, H. J., Rantala, I. S., Holli, K. A., and Isola, J. J. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am. J. Clin. Pathol., 105: 394-402, 1996.
4. Li, L., Li, X., Francke, U., and Cohen, S. N. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell, 88: 143-154, 1997.
5. Lee, J. H., Miele, M. E., Hicks, D. J., Phillips, K. K., Trent, J. M., Weissman, B. E., and Welch, D. R. KISS-1, a novel human malignant melanoma metastasis-suppressor gene. J. Natl. Cancer Inst. (Bethesda), 88: 1731-1737, 1996.
6. Buchhagen, D. L., Qiu, L., and Etkind, P. Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14.3-3p21.3 in sporadic breast cancer development. Int. J. Cancer, 57: 473-479, 1994.
7. Wick, W., Petersen, I., Schmutzler, R. K., Wolfarth, B., Lenartz, D., Bierhoff, E., Hümmerich, J., Müller, D. J., Swtangl, A. P., Schramm, J., Wiestler, O. D., and Von Deimling, A. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene, 12: 973-978, 1996.
8. Driouch, K., Dorion-Bonnet, F., Briffod, M., Champème, M. H., Longy, M., and Lidereau, R. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosomes Cancer, 19: 185-191, 1997.
9. Kuukasjärvi, T., Karhu, R., Tanner, M., Kähkönen, M., Schäffer, A., Nupponen, N., Pennanen, S., Kallioniemi, A., Kallioniemi, O. P., and Isola, J. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res., 57: 1597-1604, 1997.
10. Driouch, K., Champème, M. H., Beuzelin, M., Bièche, I., and Lidereau, R. Classical gene amplifications in human breast cancer are not associated with distant solid metastases. Br. J. Cancer, 76: 784-787, 1997.
11. Jackers, P., Minoletti, F., Beloti, D., Clausse, N., Sozzi, G., Sobel, M. E., and Castronovo, V. Isolation from a multigene family of the active human gene of the metastasis-associated multifunctional protein 37LRP/p40 at chromosome 3p21.3. Oncogene, 13: 495-503, 1996.
12. Devilee, P., Hermans, J., Eyfjord, J., Borrensen, A. L., Lidereau, R., Sobol, H., Borg, A., Cleton-Jansen, A. M., Olah, E., Cohen, B. B., Scherneck, S., Hamann, U., Peterlin, B., Caligo, M., Bignon, Y. J., Maugard, C. H., and The Breast Cancer Somatic Consortium. Loss of heterozygosity at 7q31 in breast cancer: results from an international collaborative study group. Genes Chromosomes Cancer, 18: 193-199, 1997.
13. Dorssers, L. C., Van Agthoven, T., Dekker, A., Van Agthoven, T. L., and Kok, E. M. Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of Bcar-1, a common integration site. Mol. Endocrinol., 7: 870-878, 1993.
14. Wales, M., Biel, M., Deiry, W. E., Nelkin, B., Issa, J., Cavenee, W., Kuerbitz, S., and Baylin, S. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med., 1: 570-577, 1995.
15. Mazars, R., Spinardi, L., Bencheickh, M., Simony-Lafontaine, J., Jeanteur, P., and Theillet, C. p53 mutations occur in aggressive breast cancer. Cancer Res., 52: 3918-3929, 1992.
16. Wang, Q., Driouch, K., Courtois, S., Champème, M. H., Bièche, I., Treilleux, I., Briffod M., Rimokh, R., Magaud, J. P., Curmi, P., Lidereau, R., and Puisieux, A. Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers. Oncogene, 16: 677-679, 1998.
17. Kinzler, K. W., and Vogelstein, B. Gatekeepers and caretakers. Nature (Lond.), 386: 761-763, 1997.
18. Boldog, F., Gemmill, R. M., West, J., Robinson, M., Robinson, L., Li, E., Roche, J., Todd, S., Waggoner, B., Lundstrom, R., Jacobson, J., Mullokandov, M. R., Klinger, H., and Drabkin, H. A. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum. Mol. Genet., 2: 193-203, 1997.
19. FitzGerald, M. G., Bean, J. M, Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, D. P., Finkelstein, D. M., Isselbacher, K. J., and Haber, D. A. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat. Genet., 15: 307-310, 1997.
20. Byrd, P. J., Stankovic, T., McConville, C. M., Smith, A. D., Cooper, P. R., and Taylor, A. M. R. Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23. Genome Res., 7: 71-75, 1997.